Meaningful positive changes in Eli Lilly and Co (NYSE: LLY) fundamentals have recently occurred: significant quarterly sales acceleration occurred, the consensus estimate for December, 2025 increased significantly, and significant quarterly earnings acceleration occurred.
Important positive changes in Eli Lilly and Co (NYSE: LLY) investment behavior have recently occurred: the stock’s recent price rise disrupted its longer term downtrend.
In light of these very positive signals we are reviewing our current Overall Rating of C. We would view the shares with optimism pending completion of this review in the next several days.
Current PriceTarget Research Rating
Eli Lilly has a current Value Trend Rating of C (Neutral). The Value Trend Rating reflects very contradictory signals from PTR’s two proprietary measures of a stock’s attractiveness. Eli Lilly has a good Appreciation Score of 78 but a poor Power Rating of 26, producing the Neutral Value Trend Rating.
Recent Price Action
Eli Lilly and Co (NYSE: LLY) stock closed at $825.42 on 10/1/25 after a very large increase of 8.2%. Moreover, this advance was accompanied by unusually high trading volume at 199% of normal. The stock has risen 10.5% during the last week but has been weak relative to the market over the last nine months.
Be the first to comment